Icon
+91 94997 68112
Login Register

Zanaflex - (2,4,6 mg; Capsule, Oral)

Tizanidine Hyrochloride COVIS Pharma
2,4,6 mg; Capsule, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Used to treat spasticity associated with diseases like multiple sclerosis and spinal cord injuries by temporarily relaxing muscle tone
Yes
****** ** *** ***** ** **** **** ** *** ******* ******** ** *** ** **** *** *** ************ ********* ** *** *********. ******** ***** ***** ******* ****** ** ********* *** ******* ** ******* & ***-*********. ****** *** ****** ***** *** ****** ****** ******** ******** *** ******** *** *******. ******* ** ****** ****** ** ******* * ********* ******** ****** *** ********** **** **** ***** *** ******* **** *** *** **** *** ********* ** **** ***** ******* ***** ** **** *** ******** ****** *** *********** ******.
Zanaflex Patent 1
****** ****** ******* (*** ** **)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ *** *****, **** *** ** ** ******** ******** ** *** *, ****
  1. ***. **** : ****** ******** ****** ***** *** ****** **** *,*,* ** ******** ******** *** ****** *******.
  2. ***. **** : ******* ***** * **** ******* ****** ** ******** ***** ** **.
  3. **** *, **** : ******** ***** ***** **** *** ****** *** *******.
  4. *** *, **** : ****** ******** ******** *** ******** *** *******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.